business
Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth
Pfizer is looking to newer products and acquisitions to offset a declining Covid business.
Read full story on CNBC → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from CNBC alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop